Stimulation ovarienne à fortes doses de gonadotrophines en FIV : étude rétrospective cas-témoin au CHU de Nantes

Gynécologie Obstétrique & Fertilité - Tập 44 - Trang 29-34 - 2016
M. Dercourt1,2,3, P. Barriere3,4,5, T. Freour3,4,5,6
1Service de gynécologie obstétrique, CHD de La Roche-sur-Yon, Les Oudairies, 85925 La Roche-sur-Yon cedex 9, France
2Centre AMP Procrealis, 11, boulevard René-Levesque, BP 669, 85016 La Roche-sur-Yon cedex, France
3Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, 38, boulevard Jean-Monnet, 44093 Nantes cedex 1, France
4Faculté de médecine, université de Nantes, 1, rue Gaston-Veil, 44000 Nantes, France
5Inserm UMR 1064, CHU de Nantes, immeuble Jean-Monnet, 30, boulevard Jean-Monnet, 44093 Nantes cedex 1, France
6Clínica Eugin, Travessera de les Corts, 08029 Barcelona, Espagne

Tài liệu tham khảo

Dewailly, 2014, The physiology and clinical utility of anti-Müllerian hormone in women, Hum Reprod Update, 20, 370, 10.1093/humupd/dmt062

Jayaprakasan, 2010, The cohort of antral follicles measuring 2–6mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Müllerian hormone and response to controlled ovarian stimulation, Fertil Steril, 94, 1775, 10.1016/j.fertnstert.2009.10.022

Ferraretti, 2011, ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria, Hum Reprod, 26, 1616, 10.1093/humrep/der092

Nargund, 2007, The ISMAAR proposal on terminology for ovarian stimulation for IVF, Hum Reprod, 22, 2801, 10.1093/humrep/dem285

Weghofer, 2004, Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age, Fertil Steril, 81, 1002, 10.1016/j.fertnstert.2003.09.050

Heijnen, 2007, A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial, Lancet, 369, 743, 10.1016/S0140-6736(07)60360-2

Revelli, 2011, Milder is better? Advantages and disadvantages of “mild” ovarian stimulation for human in vitro fertilization, Reprod Biol Endocrinol, 16, 9

Davis, 2014, IVF stimulation: protocols for poor responders, Methods Mol Biol, 1154, 329, 10.1007/978-1-4939-0659-8_15

Ubaldi, 2014, Management of poor responders in IVF: is there anything new?, Biomed Res Int, 2014, 352098, 10.1155/2014/352098

Tarlatzis, 2007, GnRH agonists vs antagonists, Best Pract Res Clin Obstet Gynaecol, 21, 57, 10.1016/j.bpobgyn.2006.08.002

Sunkara, 2014, Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial, Fertil Steril, 101, 147, 10.1016/j.fertnstert.2013.09.035

Dorn, 2005, FSH: what is the highest dose for ovarian stimulation that makes sense on an evidence-based level?, Reprod Biomed Online, 11, 555, 10.1016/S1472-6483(10)61163-7

Kailasam, 2004, Defining poor ovarian response during IVF cycles, in women aged<40years, and its relationship with treatment outcome, Hum Reprod, 19, 1544, 10.1093/humrep/deh273

Berkkanoglu, 2010, What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?, Fertil Steril, 94, 662, 10.1016/j.fertnstert.2009.03.027

Klinkert, 2005, Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial, Hum Reprod, 20, 611, 10.1093/humrep/deh663

Youssef, 2012, Hum Reprod, 27, ii302

Confino, 2004, GnRHa flare and IVF pregnancy rates, Int J Gynaecol Obstet, 85, 36, 10.1016/S0020-7292(03)00344-8

Monceau, 2012, 450IU versus 600IU of gonadotropins in poor responders undergoing in vitro fertilization (IVF): preliminary report of a randomized controlled trial. [abstract] Proceedings of the ASRM 68th Annual Meeting, 20 October 2012–24 October 2012, San Diego, CA, USA, Fertil Steril, 98, S77, 10.1016/j.fertnstert.2012.07.278

Haas, 2015, Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?, Gynecol Endocrinol, 31, 79, 10.3109/09513590.2014.959919

Revelli, 2014, “Mild” vs “long” protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial, J Assist Reprod Genet, 31, 809, 10.1007/s10815-014-0227-y

Yoo, 2011, Comparison of mild ovarian stimulation with conventional ovarian stimulation in poor responders, Clin Exp Reprod Med, 38, 159, 10.5653/cerm.2011.38.3.159

Matsaseng, 2013, Mild ovarian stimulation for in vitro fertilization: are we ready to change? A meta-analysis, Gynecol Obstet Invest, 76, 233, 10.1159/000355980

Polyzos, 2012, Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria, Hum Reprod, 27, 3481, 10.1093/humrep/des318

Nardo, 2013, Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee, Hum Fertil (Camb), 16, 144, 10.3109/14647273.2013.795385

Fan, 2013, Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis, Gynecol Endocrinol, 29, 278, 10.3109/09513590.2012.743016

Lehert, 2014, Recombinant human follicle stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis, Reprod Biol Endocrinol, 12, 17, 10.1186/1477-7827-12-17

Bosdou, 2012, The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis, Hum Reprod Update, 18, 127, 10.1093/humupd/dmr051

Vlahos, 2015, Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study, Reprod Biomed Online, 30, 191, 10.1016/j.rbmo.2014.10.005

Xu, 2014, Effect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria, PLoS One, 9, e99858, 10.1371/journal.pone.0099858

Massin, 2006, Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique–a prospective, randomized, double-blind study, Hum Reprod, 21, 1204, 10.1093/humrep/dei481

Boulet, 2015, Trends in use of and reproductive outcomes associated with intracytoplasmic sperm injection, JAMA, 313, 255, 10.1001/jama.2014.17985

Nelson, 2011, The journey from the old to the new AMH assay: how to avoid getting lost in the values, Reprod Biomed Online, 23, 411, 10.1016/j.rbmo.2011.06.011

Thông tin
Thông tin xuất bản

Gynécologie Obstétrique & Fertilité

Tập 44

29-34

Thông tin tác giả